Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Dextrose (D-glucose): Precision Tool for Glucose Metabolism
2026-04-27
Dextrose (D-glucose) from APExBIO is the gold-standard substrate for dissecting metabolic adaptation in hypoxic and immunosuppressive environments. This article delivers practical protocols, data-driven troubleshooting, and cross-resource insights for advanced glucose metabolism and cell culture studies.
-
iPSC-Based Multimodal Platform for Cystic Fibrosis Drug Test
2026-04-27
The referenced study introduces a robust multimodal platform using induced pluripotent stem cell (iPSC)-derived airway epithelial cells to model cystic fibrosis (CF) and assess responses to CFTR modulators. This innovation enables functional, genotype-specific in vitro drug testing for both common and rare CFTR variants, supporting the acceleration of precision therapeutics development.
-
Indole-3-pyruvic Acid Modulates Immune Balance in Rheumatoid
2026-04-26
Cheng et al. (2023) demonstrate that indole-3-pyruvic acid (IPA) alleviates rheumatoid arthritis (RA) in both patient-derived cells and animal models by restoring the Th17/Treg cell balance via activation of the aryl hydrocarbon receptor (AhR). This work provides mechanistic evidence for IPA’s immunomodulatory potential and highlights its translational relevance for autoimmune disease research.
-
Olive Biophenols Attenuate Aβ42 Pathology in AD Models
2026-04-25
This study demonstrates that olive biophenols, particularly oleuropein, verbascoside, and rutin, significantly reduce amyloid β-peptide (1-42) (Aβ42)-induced toxicity in SH-SY5Y neuroblastoma cells and decrease amyloid plaque deposition in transgenic APPswe mice. The findings highlight natural biophenols as promising modulators of Aβ42 aggregation and neurotoxicity, advancing preclinical strategies for Alzheimer's disease intervention.
-
A-769662: AMPK Activator Workflows for Metabolic Research
2026-04-24
A-769662 stands out as a potent, reversible AMPK activator enabling precise dissection of energy metabolism and fatty acid synthesis inhibition in cellular and in vivo models. This guide delivers stepwise protocols, troubleshooting insights, and the latest evidence on its nuanced role in autophagy modulation.
-
Deferoxamine Mesylate: Iron-Chelating Agent for Advanced Res
2026-04-24
Deferoxamine mesylate empowers researchers to precisely manipulate iron metabolism, oxidative stress, and hypoxia signaling in disease models. Its proven performance in tumor growth inhibition, HIF-1α stabilization, and tissue protection distinguishes it as an indispensable tool for translational workflows.
-
HotStart 2X Green qPCR Master Mix: Precision in Gene Express
2026-04-23
Harness the power of HotStart™ 2X Green qPCR Master Mix for ultra-specific, reliable real-time PCR gene expression analysis and nucleic acid quantification. This deep-dive covers advanced workflows, troubleshooting, and how to leverage recent research to maximize your results.
-
Gemcitabine HCl: Optimizing Tumor Suppression in Pancreatic
2026-04-23
Gemcitabine HCl stands out as a benchmark compound for DNA replication inhibition and apoptosis induction in pancreatic cancer research, particularly in robust KPC mouse models. This article distills experimental workflows, protocol advances, and troubleshooting insights, drawing on the latest multianimal MRI research to maximize efficiency and data quality.
-
Transcriptomic Atlas Reveals Astrocyte Regional Diversity in
2026-04-22
Schroeder et al. constructed a comprehensive transcriptomic atlas of astrocytes across multiple brain regions and developmental stages in mouse and marmoset, uncovering dynamic and region-specific molecular heterogeneity. These findings advance our understanding of astrocyte specialization and its implications for neural circuit maturation and cross-species brain biology.
-
MLKL Polymerization Drives Lysosomal Permeabilization in Nec
2026-04-22
This study elucidates how MLKL polymerization at the lysosomal membrane rapidly induces lysosomal membrane permeabilization (LMP), releasing cathepsins and driving necroptotic cell death. The findings clarify a previously unresolved mechanism of regulated necrotic cell death, highlighting the central role of MLKL-driven LMP and cathepsin activity.
-
N3-kethoxal: Precision RNA Structure Probing via Click Chemi
2026-04-21
N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) redefines RNA and DNA structure probing with membrane-permeable, azide-driven specificity for unpaired guanine. Its streamlined click chemistry compatibility and robust in vivo labeling empower researchers to unravel RNA secondary structures, protein interactions, and genomic accessibility with unprecedented resolution.
-
Lyso-Tracker Red DND-99: Quantitative Lysosome Analysis in C
2026-04-21
Explore how Lyso-Tracker Red DND-99 empowers high-precision lysosome labeling in live cells, enabling advanced quantitative analysis of lysosomal dynamics in cancer biology. This article uncovers practical assay insights and novel applications not covered elsewhere.
-
WY-14643 (Pirinixic Acid): PPARα Agonism in Translational Me
2026-04-20
This thought-leadership article explores the translational value of WY-14643 (Pirinixic Acid), a potent and selective PPARα agonist, in metabolic disorder research. Integrating mechanistic findings, recent in vivo validation, and workflow strategy, it offers a strategic guide for researchers seeking to advance metabolic, inflammatory, and regenerative studies. Featuring direct evidence from YAP-TEAD–mediated PPARα activation in murine liver regeneration and highlighting APExBIO’s product reliability, the piece contextualizes WY-14643 in the evolving competitive landscape and charts a forward-looking outlook grounded in peer-reviewed evidence.
-
miR-184 Regulates Granulosa Cell Survival via SMAD3 in Ovari
2026-04-20
This study identifies miR-184 as a critical ovary-enriched microRNA that is transcriptionally activated by SREBF2 and downregulated during follicular atresia. The authors demonstrate that miR-184 induces SMAD3 expression through both saRNA activity and mRNA stabilization, suppressing granulosa cell apoptosis and highlighting a conserved anti-atretic mechanism relevant for ovarian health.
-
ddATP in DNA Damage Response: Beyond Sequencing Applications
2026-04-19
Uncover the advanced role of ddATP (2',3'-dideoxyadenosine triphosphate) in DNA damage response and break-induced replication studies. This in-depth analysis explores mechanisms and practical insights not found in standard Sanger sequencing guides.